Magnitude Biosciences
PrivateLast Round
Seed
May 27, 2025
Total Funding Raised
$3.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Magnitude Biosciences is a biotechnology company that provides contract research services using a patented in-vivo testing platform with C. elegans and automated imaging technology to accelerate drug discovery and toxicity testing.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magnitude Biosciences Comparables
Compare Magnitude Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ora Biomedical, Inc. | 87% | |
| InVivo Biosystems | 83% | |
| vivoVerse | 83% |
Magnitude Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2025 | ||||
| Grant | Jun 5, 2023 | ||||
| Grant | Nov 15, 2022 | ||||
| Convertible Debt | Aug 21, 2020 | ||||
| Seed | Dec 2, 2019 | ||||
Seed | Sep 1, 2019 |
Magnitude Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Fund | Convertible Debt |
| British Business Bank | Seed |
| Innovate UK | Grant, Seed |
| Saker Capital LLP | Grant, Convertible Debt, Seed |
| Northstar Ventures | Convertible Debt, Grant, Seed |
| Innovate UK | Seed |
| Maven Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 42% MoM.
- Jun 19, 2026
Monthly visitors grew 6464% MoM, from 28 to 1.8K.
Recent news
Latest coverage and updates
- receives_financingSep 16, 2026
Magnitude Biosciences Ltd. received financing of $1.3M in funding round on Sep 17th '26.
- invests_into_assetsSep 16, 2026
New funding helps Magnitude Biosciences Ltd. invest in equipment and automation, scale its VivoScan(TM) platform, expand commercial work with pharmaceutical companies and recruit staff.
- receives_financingSep 15, 2026
Magnitude Biosciences Ltd. can access a $291K Innovate UK Investor Partnership grant as part of its Northstar Ventures-led £1.3m funding round, which includes Maven-managed regional funds and new angel investors and supports scaling its VivoScan platform.
- receives_financingSep 15, 2026
Magnitude Biosciences Ltd. has secured $1.74M in funding to accelerate the commercialisation of its VivoScan™ in vivo high-throughput screening platform in United Kingdom on Sep 15th '26.
Magnitude Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Magnitude Biosciences's valuation, stock price, and market status.
Is Magnitude Biosciences a public or private company?
Magnitude Biosciences is a private company.
What is the current stock price of Magnitude Biosciences?
Magnitude Biosciences is a private company, so its shares have no public market price. Caplight tracks Magnitude Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magnitude Biosciences worth (valuation)?
Valuation information for Magnitude Biosciences is not publicly available.
Can I buy Magnitude Biosciences stock?
Magnitude Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magnitude Biosciences's last funding round?
Magnitude Biosciences's most recent funding round was Seed on May 27, 2025.
Who are the main investors in Magnitude Biosciences?
Key investors in Magnitude Biosciences include Innovate UK, Northstar Ventures, Maven Capital Partners.
Will Magnitude Biosciences IPO soon?
No public IPO plans have been announced for Magnitude Biosciences.
How can I track Magnitude Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Magnitude Biosciences's shares on secondary markets.